| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.789 | 16.974 | 16.955 | 8.808 | 7.018 | 4.790 | 1.001 | 722 |
| Total Income - EUR | - | - | 11.789 | 16.974 | 16.955 | 8.808 | 7.018 | 4.790 | 1.001 | 722 |
| Total Expenses - EUR | - | - | 2.950 | 3.966 | 8.060 | 14.950 | 14.588 | 14.081 | 9.751 | 2.840 |
| Gross Profit/Loss - EUR | - | - | 8.840 | 13.008 | 8.895 | -6.143 | -7.570 | -9.291 | -8.750 | -2.118 |
| Net Profit/Loss - EUR | - | - | 8.490 | 12.505 | 8.387 | -6.340 | -7.634 | -9.435 | -8.750 | -2.118 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medical Pathology-Dr. Mazuch Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 8.012 | 6.828 | 42.401 | 31.199 | 19.746 | 9.056 | 1.739 | 802 |
| Current Assets | - | - | 2.217 | 14.163 | 7.145 | 10.946 | 13.880 | 15.158 | 199 | 48 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 228 | 1.212 | 598 | 0 | 31 | 0 | 0 | 0 |
| Cash | - | - | 1.989 | 12.951 | 6.546 | 10.946 | 13.850 | 15.158 | 199 | 48 |
| Shareholders Funds | - | - | 8.534 | 20.882 | 23.617 | 16.830 | 8.823 | -585 | -9.333 | -11.399 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.695 | 109 | 25.929 | 25.315 | 24.804 | 24.799 | 11.271 | 12.249 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medical Pathology-Dr. Mazuch Srl